These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20460174)

  • 1. Randomisation in double-blind multicentre trials with many treatments.
    Morrissey M; McEntegart D; Lang M
    Contemp Clin Trials; 2010 Jul; 31(4):381-91. PubMed ID: 20460174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blinded sample size recalculation in multicentre trials with normally distributed outcome.
    Jensen K; Kieser M
    Biom J; 2010 Jun; 52(3):377-99. PubMed ID: 20394080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conducting research in individual patients: lessons learnt from two series of N-of-1 trials.
    Wegman AC; van der Windt DA; Stalman WA; de Vries TP
    BMC Fam Pract; 2006 Sep; 7():54. PubMed ID: 16984636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analysis of continuous outcomes in multi-centre trials with small centre sizes.
    Pickering RM; Weatherall M
    Stat Med; 2007 Dec; 26(30):5445-56. PubMed ID: 17924360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A generic minimization random allocation and blinding system on web.
    Cai H; Xia J; Xu D; Gao D; Yan Y
    J Biomed Inform; 2006 Dec; 39(6):706-19. PubMed ID: 16616696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of fatal pulmonary embolism in general surgery using low-molecular weight heparin Cy 216: a multicentre, double-blind, randomized, controlled, clinical trial versus placebo (STEP). STEP-Study Group.
    Pezzuoli G; Neri Serneri GG; Settembrini P; Coggi G; Olivari N; Buzzetti G; Chierichetti S; Scotti A; Scatigna M; Carnovali M
    Int Surg; 1989; 74(4):205-10. PubMed ID: 2560470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Web-based randomised controlled trials in orthodontics.
    Cioffi I; Martina R; Michelotti A; Chiodini P; Tagliaferri R; Farella M
    Evid Based Dent; 2008; 9(4):118-20. PubMed ID: 19151687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality management of a large randomized double-blind multi-centre trial: the ACTION experience.
    Kirwan BA; Lubsen J; de Brouwer S; van Dalen FJ; Pocock SJ; Clayton T; Danchin N; Poole-Wilson PA;
    Contemp Clin Trials; 2008 Mar; 29(2):259-69. PubMed ID: 18029294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimising the design of phase II oncology trials: the importance of randomisation.
    Ratain MJ; Sargent DJ
    Eur J Cancer; 2009 Jan; 45(2):275-80. PubMed ID: 19059773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity.
    Colagiuri B
    Clin Trials; 2010 Jun; 7(3):246-55. PubMed ID: 20421243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balancing treatment allocations by clinician or center in randomized trials allows unacceptable levels of treatment prediction.
    Hills RK; Gray R; Wheatley K
    J Evid Based Med; 2009 Aug; 2(3):196-204. PubMed ID: 21349013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative clinical trials].
    Yokoyama M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):404-12. PubMed ID: 6703720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple testing procedures based on weighted Kaplan-Meier statistics for right-censored survival data.
    Chi Y
    Stat Med; 2005 Jan; 24(1):23-35. PubMed ID: 15515153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomization by minimization for unbalanced treatment allocation.
    Han B; Enas NH; McEntegart D
    Stat Med; 2009 Nov; 28(27):3329-46. PubMed ID: 19739238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological factors in clinical trial design.
    Wassilak S
    Dev Biol Stand; 1998; 95():75-83. PubMed ID: 9855417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficiency of investigators in recruitment of patients for clinical trials: apropos of a multinational study].
    Dal-Ré R; Ortega R; Espada J
    Med Clin (Barc); 1998 Apr; 110(14):521-3. PubMed ID: 9646264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke.
    Bath PM; Macleod MR; Green AR
    Int J Stroke; 2009 Dec; 4(6):471-9. PubMed ID: 19930059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.